ES301814A1 - Procedimiento para la obtencion de nuevos acidos aminicos. - Google Patents

Procedimiento para la obtencion de nuevos acidos aminicos.

Info

Publication number
ES301814A1
ES301814A1 ES0301814A ES301814A ES301814A1 ES 301814 A1 ES301814 A1 ES 301814A1 ES 0301814 A ES0301814 A ES 0301814A ES 301814 A ES301814 A ES 301814A ES 301814 A1 ES301814 A1 ES 301814A1
Authority
ES
Spain
Prior art keywords
translation
procedure
machine
legally binding
*** translate
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES0301814A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis AG
BASF Schweiz AG
Original Assignee
Ciba Geigy AG
Ciba AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from CH853763A external-priority patent/CH446376A/de
Application filed by Ciba Geigy AG, Ciba AG filed Critical Ciba Geigy AG
Publication of ES301814A1 publication Critical patent/ES301814A1/es
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/18Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D207/22Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/24Oxygen or sulfur atoms
    • C07D207/262-Pyrrolidones
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/195Carboxylic acids, e.g. valproic acid having an amino group
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/80Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D211/84Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
    • C07D211/86Oxygen atoms
    • C07D211/88Oxygen atoms attached in positions 2 and 6, e.g. glutarimide

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
ES0301814A 1963-07-09 1964-07-08 Procedimiento para la obtencion de nuevos acidos aminicos. Expired ES301814A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH853763A CH446376A (de) 1963-07-09 1963-07-09 Verfahren zur Herstellung neuer Aminosäuren
CH672964 1964-05-22

Publications (1)

Publication Number Publication Date
ES301814A1 true ES301814A1 (es) 1965-01-01

Family

ID=25700075

Family Applications (1)

Application Number Title Priority Date Filing Date
ES0301814A Expired ES301814A1 (es) 1963-07-09 1964-07-08 Procedimiento para la obtencion de nuevos acidos aminicos.

Country Status (9)

Country Link
US (1) US3471548A (es)
BE (1) BE650258A (es)
BR (1) BR6460727D0 (es)
CH (1) CH449645A (es)
DE (1) DE1493536B1 (es)
ES (1) ES301814A1 (es)
FR (2) FR3677M (es)
GB (1) GB1017439A (es)
SE (4) SE333151B (es)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3956314A (en) * 1970-07-24 1976-05-11 U.C.B., Societe Anonyme Derivatives of 2-pyrrolidinone
US3947579A (en) * 1974-06-03 1976-03-30 Nelson Research & Development Company Method and composition for potentiating neuroleptic drugs
US3978216A (en) * 1974-06-03 1976-08-31 Nelson Research & Development Company Method for treating schizophrenia and method and composition for potentiating neuroleptic drugs
US4084000A (en) * 1975-07-16 1978-04-11 Nelson Research And Development Company Method of treating schizophrenia
US4126684A (en) * 1976-02-11 1978-11-21 Ciba-Geigy Corporation 4-amino-3-p-halophenylbutyric acids and their derivatives used in the control of narcotic abuse
NL7706429A (nl) * 1977-06-10 1978-12-12 Univ Erasmus Werkwijze voor de bereiding van een geneesmid- del met angst en angstequivalenten opheffende werking en gevormd geneesmiddel met een derge- lijke werking.
NL8006135A (nl) * 1980-11-10 1982-06-01 Univ Erasmus Geneesmiddel met angst en angstequivalenten opheffende werking en werkwijze voor de bereiding van een dergelijk geneesmiddel.
US5006560A (en) * 1989-12-20 1991-04-09 Schering Corporation Use of GABA-B selective agonists as anti-tussive agents
WO1997022578A1 (en) * 1995-12-20 1997-06-26 Farmarc Nederland B.V. A process for the optical resolution of 3-(p-chlorophenyl)-glutaramide
PL189872B1 (pl) 1996-07-24 2005-10-31 Warner Lambert Co Zastosowanie izobutylogaby i jej pochodnych do wytwarzania leku do leczenia bólu
EA200300433A1 (ru) 2000-11-30 2003-10-30 Пфайзер Продактс Инк. Комбинация гамк-агонистов и ингибиторов альдегидредуктазы
KR20030059290A (ko) 2000-11-30 2003-07-07 화이자 프로덕츠 인코포레이티드 Gaba 작용제 및 소르비톨 데하이드로게나제 억제제의혼합물
BRPI0410271A (pt) * 2003-05-16 2006-05-16 Pfizer Prod Inc combinações terapêuticas de antipsicóticos atìpicos com moduladores de gaba, anticonvulsivantes ou benzodiazepinas
PT1660440E (pt) * 2003-08-20 2012-05-15 Xenoport Inc Pró-fármacos de aciloxialquilcarbamato, métodos de síntese e utilização
EP2354120A1 (en) 2003-08-20 2011-08-10 XenoPort, Inc. Synthesis of acyloxyalkyl carbamate prodrugs and intermediates thereof
PL1691811T3 (pl) 2003-12-11 2014-12-31 Sunovion Pharmaceuticals Inc Skojarzenie leku uspokajającego i modulatora neuroprzekaźnikowego oraz sposoby poprawy jakości snu i leczenia depresji
WO2005082372A1 (en) * 2004-01-29 2005-09-09 Pfizer Products Inc. COMBINATION OF γ-AMINOBUTYRIC ACID MODULATORS AND 5-HT 1B RECEPTOR ANTAGONISTS
WO2007025177A2 (en) 2005-08-26 2007-03-01 Braincells, Inc. Neurogenesis by muscarinic receptor modulation
EP2258358A3 (en) 2005-08-26 2011-09-07 Braincells, Inc. Neurogenesis with acetylcholinesterase inhibitor
EP2377530A3 (en) 2005-10-21 2012-06-20 Braincells, Inc. Modulation of neurogenesis by PDE inhibition
US20070112017A1 (en) 2005-10-31 2007-05-17 Braincells, Inc. Gaba receptor mediated modulation of neurogenesis
US20100216734A1 (en) 2006-03-08 2010-08-26 Braincells, Inc. Modulation of neurogenesis by nootropic agents
US7678808B2 (en) 2006-05-09 2010-03-16 Braincells, Inc. 5 HT receptor mediated neurogenesis
EP2377531A2 (en) 2006-05-09 2011-10-19 Braincells, Inc. Neurogenesis by modulating angiotensin
US20100197789A1 (en) 2006-08-11 2010-08-05 National University Corporation Nagoya University Anti-obesity agent and use thereof
MX2009002496A (es) 2006-09-08 2009-07-10 Braincells Inc Combinaciones que contienen un derivado de 4-acilaminopiridina.
US20100184806A1 (en) 2006-09-19 2010-07-22 Braincells, Inc. Modulation of neurogenesis by ppar agents
KR20090121388A (ko) * 2007-03-15 2009-11-25 썬 파마 어드밴스트 리서치 컴패니 리미티드 신규 전구약물
WO2010099217A1 (en) 2009-02-25 2010-09-02 Braincells, Inc. Modulation of neurogenesis using d-cycloserine combinations
WO2011113904A1 (en) 2010-03-17 2011-09-22 INSERM (Institut National de la Santé et de la Recherche Médicale) Medicaments for the prevention and treatment of a disease associated with retinal ganglion cell degeneration
EP3322691A4 (en) 2015-07-13 2019-03-27 Piramal Enterprises Limited IMPROVED PROCESS FOR THE PREPARATION OF BACLOFEN AND ITS INTERMEDIATE
CN106187794A (zh) * 2016-07-12 2016-12-07 安徽省逸欣铭医药科技有限公司 一种巴氯芬的绿色工业化生产方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3125583A (en) * 1964-03-17 Hjnc oxchaxohxchc o oh

Also Published As

Publication number Publication date
SE348460B (es) 1972-09-04
SE333151B (sv) 1971-03-08
BE650258A (es) 1965-01-08
FR3677M (fr) 1965-11-08
DE1493536B1 (de) 1971-10-14
BR6460727D0 (pt) 1973-08-02
SE348462B (es) 1972-09-04
SE348461B (es) 1972-09-04
CH449645A (de) 1968-01-15
US3471548A (en) 1969-10-07
GB1017439A (en) 1966-01-19
FR3692M (fr) 1965-11-15

Similar Documents

Publication Publication Date Title
ES301814A1 (es) Procedimiento para la obtencion de nuevos acidos aminicos.
ES307302A1 (es) Procedimiento para preparar nuevos 6,7-benzomorfanos sustituidos.
ES296709A1 (es) Procedimiento para la preparación de nuevos éteres difenílicos sustituidos
ES414956A1 (es) Procedimiento para la preparacion de 4-(4-bifenilil)-buta- noles.
ES321531A1 (es) Procedimiento para la fabricacion de nuevas 7-(picolilaminoalquilteofilinas).
ES325146A1 (es) Un procedimiento para la preparacion de aminoisoxazoles.
ES302819A1 (es) Un procedimiento para la preparacion de nuevos sulfanilamidoisoxazoles.
ES378206A1 (es) Procedimiento para la preparacion de nuevos 2-amino-5-ni- trotiazoles.
ES307941A1 (es) Procedimiento para la produccion de compuestos heterociclicos del acido sulfonil-carbamico.
ES274330A1 (es) Procedimiento para la preparacion de nuevos compuestos de 1,5-benzodioxepano
ES433723A1 (es) Procedimiento de obtencion de un derivado de 2-pirrolidi- nona.
ES311200A1 (es) Procedimiento para la obtencion de compuestos piperacinicos.
ES298470A1 (es) Procedimiento para la obtención de nuevos compuestos de ftalacina
ES245280A1 (es) Procedimiento para la obtencion de nuevas pirazolo-pirimidinas 1-sustituidas
ES313955A1 (es) Procedimiento para la obtencion de compuestos heterociclicospiperidinicos
ES360938A1 (es) Procedimiento para la preparacion de nuevas amidas de acidocinamico.
ES317256A1 (es) Procedimiento para la obtencion de aminas secundarias.
ES294914A1 (es) Procedimiento para la obtenciën de nuevos derivados del acido-fenoxi-isobutirico
ES297157A1 (es) Procedimiento para la obtenciën de compuestos activos para la circulaciën
ES390479A2 (es) Procedimiento de preparacion de derivados de hidroxiproli- na.
ES312597A1 (es) Un procedimiento para la produccion de la naft (2,3,b) - indolizin-6,11-diona-12-carboxigenilamidas.
ES304850A1 (es) Procedimiento para la obtencion de nuevas aminohalogeno-bencilaminas
ES306430A1 (es) Procedimiento para preparar una mezcla de acido bis-(o-hidroxifenilacetico) de etilendiamina y de su monoamida.
ES309744A1 (es) Procedimiento para la obtencion de aminas.
ES276940A1 (es) Procedimiento para la obtención de aminas secundarias